BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9812231)

  • 1. New paradigm for ASCUS diagnosis using neural networks.
    Kok MR; Habers MA; Schreiner-Kok PG; Boon ME
    Diagn Cytopathol; 1998 Nov; 19(5):361-6. PubMed ID: 9812231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAPNET-directed rescreening of cervicovaginal smears: a study of 101 cases of atypical squamous cells of undetermined significance.
    Ryan MR; Stastny JF; Remmers R; Pedigo MA; Cahill LA; Frable WJ
    Am J Clin Pathol; 1996 Jun; 105(6):711-8. PubMed ID: 8659445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An interlaboratory study of the use of PapNet in the quality control of cervico-vaginal cytology].
    Cosentino A; Ghidoni D; Salemi M; Folicaldi S; Amadori A; Zani J; Grasso G; Bondi A
    Pathologica; 1999 Apr; 91(2):101-6. PubMed ID: 10484869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.
    van Ballegooijen M; Beck S; Boon ME; Boer R; Habbema JD
    Acta Cytol; 1998; 42(5):1133-8. PubMed ID: 9755670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASCUS diagnoses.
    Frankel KA
    Acta Cytol; 1998; 42(1):271-2. PubMed ID: 9479351
    [No Abstract]   [Full Text] [Related]  

  • 6. Rescreening of atypical cervicovaginal smears using PAPNET.
    Lerma E; Colomo L; Carreras A; Esteva E; Quilez M; Prat J
    Cancer; 1998 Dec; 84(6):361-5. PubMed ID: 9915138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASCUS on cervical cytologic smears. Clinical significance.
    Yang M; Zachariah S
    J Reprod Med; 1997 Jun; 42(6):329-31. PubMed ID: 9219118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
    Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
    Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
    Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
    Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it possible to define a better ASCUS class in cervicovaginal screening? A review of 187 cases.
    Guerrini L; Sama D; Visani M; Cotignoli T; Sintoni C; Maioli P; Lanzanova G; Schincaglia P
    Acta Cytol; 2001; 45(4):532-6. PubMed ID: 11480714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
    Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
    Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
    Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of unsuspected abnormalities by PAPNET-assisted review.
    Mitchell H; Medley G
    Acta Cytol; 1998; 42(1):260-4. PubMed ID: 9479349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from neural networks (PAPNET) to the Imager (Hologic) for computer-assisted screening.
    Boon ME; Ouwerkerk-Noordam E; Meijer-Marres EM; Bontekoe TR
    Acta Cytol; 2011; 55(2):163-6. PubMed ID: 21325801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAPNET testing for HSILs. The few cell/small cell challenge.
    Solomon HM; Frist S
    Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
    Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
    Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytological classifications of vaginal smears. Current concepts of complex cytodiagnosis].
    Kasabova M
    Akush Ginekol (Sofiia); 1984; 23(4):357-64. PubMed ID: 6385754
    [No Abstract]   [Full Text] [Related]  

  • 19. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAPNET for analysis of proliferating (MIB-1 positive) cell populations in cervical smears.
    Boon ME; Kleinschmidt-Guy ED; Ouwerkerk-Noordam E
    Eur J Morphol; 1994 Mar; 32(1):78-85. PubMed ID: 8086271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.